Cowen Analyst Says Amazon Should Buy Rite Aid

11/21/17

By Brandy Betz, SeekingAlpha

A Cowen analyst says Amazon (NASDAQ:AMZN) should acquire Rite Aid (NYSE:RAD) for faster access to the legal side of the pharmacy business.

Analyst John Blackledge says the Rite Aid buy would bring along pharmacy licenses and infrastructure that could benefit the company if moving to open pharmacies in Whole Foods or to offer medication through the Prime services.

Blackledge says the firm’s research shows that 67% of Amazon Prime members would buy prescription drugs through the platform.

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.